Home
Inbox
Search
Event
P1019 Fevipiprant (QAW039) for Treatment of Patients with Uncontrolled Severe Asthma: Design of LUSTER1, a Phase III One-Year Exacerbation Study
Monday
May
22
9:15 AM
4:15 PM
Type :
Scientific Abstract
Speaker(s)
Christopher E. Brightling
Sally E. Wenzel
Caterina Brindicci
Florian Brockhaus
Pamela Cardenas
Björn Holzhauer
Barbara Knorr
Content
Parent Sessions
B32 THERAPEUTIC TRIALS IN ASTHMA
05-22-2017
9:15 AM - 4:15 PM
Home
Inbox
Search